Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT04386031
Other study ID # 0196-19-RMB CTIL
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date June 1, 2020
Est. completion date May 1, 2022

Study information

Verified date May 2020
Source Rambam Health Care Campus
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

this prospective study we will examine the prevalence of fungal infection in patients undergoing oral cavity surgery without treatment with antifungal drug


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 80
Est. completion date May 1, 2022
Est. primary completion date May 1, 2022
Accepts healthy volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Age over 18

Exclusion Criteria:

- Previous oral cavity surgery.

- Previous radiotherapy to the head and neck.

- Previous treatment with antifungal drugs in the 30 days preceding the surgery Immunocompomised state at the date of surgery.

- Pregnancy

- Lack of follow-up

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
Throat culture for fungal pathogens
Throat culture for fungal pathogens will be taken before surgery, at post-operative day (POD) 3 and 2 weeks after the operation

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Rambam Health Care Campus

Outcome

Type Measure Description Time frame Safety issue
Primary prevalence of fungal infection in patients undergoing oral cavity surgery without treatment with antifungal drug. 40 patients undergoing oral cavity surgery and 40 patients (control group) undergoing thyroidectomy or parotidectomy for our research measurement :Throat culture for fungal pathogens 2 years